Cargando…
High-flow Nasal Oxygen Therapy in COVID-19 Critically Ill Patients with Acute Hypoxemic Respiratory Failure: A Prospective Observational Cohort Study
BACKGROUND: Coronavirus disease-2019 (COVID-19) is prone to acute hypoxemic respiratory failure (AHRF). Because tracheal intubation is associated with a higher risk of death in these patients, AHRF employs high-flow nasal oxygen therapy (HFNOT). The goal of this study was to assess the effect of HFN...
Autores principales: | Khan, Mohd Saif, Prakash, Jay, Banerjee, Sudipto, Bhattacharya, Pradip K, Kumar, Raman, Nirala, Deepak K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160615/ https://www.ncbi.nlm.nih.gov/pubmed/35719441 http://dx.doi.org/10.5005/jp-journals-10071-24167 |
Ejemplares similares
-
Surgical mask on top of high-flow nasal cannula improves oxygenation in critically ill COVID-19 patients with hypoxemic respiratory failure
por: Montiel, Virginie, et al.
Publicado: (2020) -
ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: A systematic review and meta-analysis
por: Prakash, Jay, et al.
Publicado: (2021) -
High flow nasal cannula oxygen therapy in immunocompromised patients with acute hypoxemic respiratory failure
por: Frat, J-P, et al.
Publicado: (2015) -
Effects of high-flow nasal cannula therapy on oxygenation, lung volumes and CO(2) removal in critically ill hypoxemic patients: preliminary results
por: Mauri, T, et al.
Publicado: (2015) -
Should high-flow through nasal cannula be used during bronchoscopy in critically ill patients with hypoxemic acute respiratory failure?
por: Longhini, Federico, et al.
Publicado: (2021)